FDA: Oral medication not approved for infant teething

By KBJR News 1

FDA: Oral medication not approved for infant teething

June 26, 2014 Updated Jun 26, 2014 at 2:48 PM CDT

Washington D.C. (NNCNOW.com) - The Federal Drug Administration is notifying the public that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain.

FDA is requiring a boxed warning to be added to the label to highlight this information.

Oral viscous lidocaine solution is not approved to treat teething pain, and use in infants and young children can cause serious harm, including death.

Topical pain relievers and medications that are rubbed on the gums are not necessary or even useful because they wash out of the baby's mouth within minutes.

Experts say when too much viscous lidocaine is given to infants and young children or they accidentally swallow too much, it can result in seizures, severe brain injury, and problems with the heart.

Cases of overdose due to wrong dosage or accidental ingestion have resulted in infants and children being hospitalized or dying.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.